{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:07:47Z","timestamp":1788458867608,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00228-024-03692-8","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:01:45Z","timestamp":1714608105000},"page":"1229-1240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["External validation of population pharmacokinetic models of tacrolimus in Thai adult liver transplant recipients"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8711-2752","authenticated-orcid":false,"given":"Virunya","family":"Komenkul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9331-1734","authenticated-orcid":false,"given":"Waroonrat","family":"Sukarnjanaset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7890-8356","authenticated-orcid":false,"given":"Piyawat","family":"Komolmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1474-4249","authenticated-orcid":false,"given":"Thitima","family":"Wattanavijitkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"issue":"3","key":"3692_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/ftd.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, van Gelder T, \u00c5sberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Mill\u00e1n O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S (2019) Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit 41(3):261\u2013307. https:\/\/doi.org\/10.1097\/ftd.0000000000000640","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3692_CR2","first-page":"2736","volume":"23","author":"R Venkataramanan","year":"1991","unstructured":"Venkataramanan R, Jain A, Warty VS, Abu-Elmagd K, Alessiani M, Lever J, Krajak A, Flowers J, Mehta S, Zuckerman S et al (1991) Pharmacokinetics of FK 506 in transplant patients. Transplant Proc 23(6):2736\u20132740","journal-title":"Transplant Proc"},{"issue":"6","key":"3692_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","volume":"29","author":"R Venkataramanan","year":"1995","unstructured":"Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T (1995) Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 29(6):404\u2013430. https:\/\/doi.org\/10.2165\/00003088-199529060-00003","journal-title":"Clin Pharmacokinet"},{"key":"3692_CR4","first-page":"2018","volume-title":"Winter\u2019s basic clinical pharmacokinetics","author":"P Beringer","year":"2018","unstructured":"Beringer P (2018) Winter\u2019s basic clinical pharmacokinetics. Wolters Kluwer Health, Philadelphia, p 2018"},{"issue":"10","key":"3692_CR5","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1345\/aph.1D374","volume":"38","author":"EI Ette","year":"2004","unstructured":"Ette EI, Williams PJ (2004) Population pharmacokinetics I: background, concepts, and models. Ann Pharmacother 38(10):1702\u20131706. https:\/\/doi.org\/10.1345\/aph.1D374","journal-title":"Ann Pharmacother"},{"issue":"5\u20136","key":"3692_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00228-005-0933-6","volume":"61","author":"M Antignac","year":"2005","unstructured":"Antignac M, Hulot JS, Boleslawski E, Hannoun L, Touitou Y, Farinotti R, Lechat P, Urien S (2005) Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance. Eur J Clin Pharmacol 61(5\u20136):409\u2013416. https:\/\/doi.org\/10.1007\/s00228-005-0933-6","journal-title":"Eur J Clin Pharmacol"},{"issue":"6\u20137","key":"3692_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s002280100331","volume":"57","author":"S Fukatsu","year":"2001","unstructured":"Fukatsu S, Yano I, Igarashi T, Hashida T, Takayanagi K, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K, Tanaka K, Inui K (2001) Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. Eur J Clin Pharmacol 57(6\u20137):479\u2013484. https:\/\/doi.org\/10.1007\/s002280100331","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"3692_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00003088-200645010-00004","volume":"45","author":"WJ Sam","year":"2006","unstructured":"Sam WJ, Tham LS, Holmes MJ, Aw M, Quak SH, Lee KH, Lim SG, Prabhakaran K, Chan SY, Ho PC (2006) Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Clin Pharmacokinet 45(1):59\u201375. https:\/\/doi.org\/10.2165\/00003088-200645010-00004","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"3692_CR9","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/s0041-1345(98)00234-6","volume":"30","author":"NA Undre","year":"1998","unstructured":"Undre NA, Sch\u00e4fer A (1998) Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. Transplant Proc 30(4):1261\u20131263. https:\/\/doi.org\/10.1016\/s0041-1345(98)00234-6","journal-title":"Transplant Proc"},{"issue":"4","key":"3692_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/FTD.0b013e318178e31b","volume":"30","author":"B Blanchet","year":"2008","unstructured":"Blanchet B, Duvoux C, Costentin CE, Barrault C, Ghaleh B, Salvat A, Jouault H, Astier A, Tod M, Hulin A (2008) Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period. Ther Drug Monit 30(4):412\u2013418. https:\/\/doi.org\/10.1097\/FTD.0b013e318178e31b","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3692_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/jcpt.12599","volume":"42","author":"B Chen","year":"2017","unstructured":"Chen B, Shi HQ, Liu XX, Zhang WX, Lu JQ, Xu BM, Chen H (2017) Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients. J Clin Pharm Ther 42(6):679\u2013688. https:\/\/doi.org\/10.1111\/jcpt.12599","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"3692_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.clpt.2006.06.008","volume":"80","author":"M Fukudo","year":"2006","unstructured":"Fukudo M, Yano I, Masuda S, Goto M, Uesugi M, Katsura T, Ogura Y, Oike F, Takada Y, Egawa H, Uemoto S, Ki I (2006) Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin Pharmacol Ther 80(4):331\u2013345. https:\/\/doi.org\/10.1016\/j.clpt.2006.06.008","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"3692_CR13","first-page":"535","volume":"29","author":"Z Li","year":"2007","unstructured":"Li Z, Fan Q, Zhang N, Zhang C (2007) Population pharmacokinetic estimation of tacrolimus apparent clearance through multiple-linear regression. J Dalian Med Univ 29(6):535\u2013538","journal-title":"J Dalian Med Univ"},{"issue":"11","key":"3692_CR14","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/cpdd.971","volume":"10","author":"Y Lu","year":"2021","unstructured":"Lu Y, Xu L, Cui J, Shen S, Li X (2021) Effects of postoperative day and NR1I2 on tacrolimus clearance in Chinese liver transplant recipients-a population model approach. Clin Pharmacol Drug Dev 10(11):1385\u20131394. https:\/\/doi.org\/10.1002\/cpdd.971","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"2","key":"3692_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/aps.2014.110","volume":"36","author":"YX Lu","year":"2015","unstructured":"Lu YX, Su QH, Wu KH, Ren YP, Li L, Zhou TY, Lu W (2015) A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. Acta Pharmacol Sin 36(2):281\u2013288. https:\/\/doi.org\/10.1038\/aps.2014.110","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"3692_CR16","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1111\/bcp.14842","volume":"87","author":"LC Martial","year":"2021","unstructured":"Martial LC, Biewenga M, Ruijter BN, Keizer R, Swen JJ, van Hoek B, Moes D (2021) Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients. Br J Clin Pharmacol 87(11):4262\u20134272. https:\/\/doi.org\/10.1111\/bcp.14842","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"3692_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00228-012-1300-z","volume":"69","author":"I Oteo","year":"2013","unstructured":"Oteo I, Lukas JC, Leal N, Suarez E, Valdivieso A, Gastaca M, Ortiz de Urbina J, Calvo R (2013) Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction. Eur J Clin Pharmacol 69(1):65\u201374. https:\/\/doi.org\/10.1007\/s00228-012-1300-z","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"3692_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/1060028019897050","volume":"54","author":"J Shao","year":"2020","unstructured":"Shao J, Wang C, Fu P, Chen F, Zhang Y, Wei J (2020) Impact of donor and recipient CYP3A5*3 genotype on tacrolimus population pharmacokinetics in Chinese adult liver transplant recipients. Ann Pharmacother 54(7):652\u2013661. https:\/\/doi.org\/10.1177\/1060028019897050","journal-title":"Ann Pharmacother"},{"issue":"2","key":"3692_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/jlts.2003.50023","volume":"9","author":"CE Staatz","year":"2003","unstructured":"Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE (2003) Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transpl 9(2):130\u2013137. https:\/\/doi.org\/10.1053\/jlts.2003.50023","journal-title":"Liver Transpl"},{"issue":"1","key":"3692_CR20","first-page":"17","volume":"16","author":"VSA Tharanon","year":"2021","unstructured":"Tharanon VSA, Intaraprasong P, Sra-ium S, Sakulchairungrueng B, Gesprasert G, Arpornsujaritkun N (2021) Population pharmacokinetics of tacrolimus in Thai liver transplant patients. Thai Bull Pharm Sci 16(1):17\u201330","journal-title":"Thai Bull Pharm Sci"},{"issue":"2","key":"3692_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/FTD.0b013e31824a67eb","volume":"34","author":"XQ Zhang","year":"2012","unstructured":"Zhang XQ, Wang ZW, Fan JW, Li YP, Jiao Z, Gao JW, Peng ZH, Liu GL (2012) The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients. Ther Drug Monit 34(2):126\u2013133. https:\/\/doi.org\/10.1097\/FTD.0b013e31824a67eb","journal-title":"Ther Drug Monit"},{"key":"3692_CR22","doi-asserted-by":"publisher","first-page":"713650","DOI":"10.1155\/2014\/713650","volume":"2014","author":"L Zhu","year":"2014","unstructured":"Zhu L, Wang H, Sun X, Rao W, Qu W, Zhang Y, Sun L (2014) The population pharmacokinetic models of tacrolimus in Chinese adult liver transplantation patients. J Pharm (Cairo) 2014:713650. https:\/\/doi.org\/10.1155\/2014\/713650","journal-title":"J Pharm (Cairo)"},{"key":"3692_CR23","doi-asserted-by":"publisher","first-page":"105237","DOI":"10.1016\/j.ejps.2020.105237","volume":"145","author":"X Cai","year":"2020","unstructured":"Cai X, Li R, Sheng C, Tao Y, Zhang Q, Zhang X, Li J, Shen C, Qiu X, Wang Z, Jiao Z (2020) Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients. Eur J Pharm Sci 145:105237. https:\/\/doi.org\/10.1016\/j.ejps.2020.105237","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3692_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s40262-020-00937-4","volume":"60","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Wang CY, Li ZR, Pan Y, Liu MB, Jiao Z (2021) Can population pharmacokinetics of antibiotics be extrapolated? Implications of external evaluations Clin Pharmacokinet 60(1):53\u201368. https:\/\/doi.org\/10.1007\/s40262-020-00937-4","journal-title":"Implications of external evaluations Clin Pharmacokinet"},{"issue":"4","key":"3692_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/00498254.2019.1631505","volume":"50","author":"DD Wang","year":"2020","unstructured":"Wang DD, Chen X, Fu M, Zheng QS, Xu H, Li ZP (2020) Model extrapolation to a real-world dataset: evaluation of tacrolimus population pharmacokinetics and drug interaction in pediatric liver transplantation patients. Xenobiotica 50(4):371\u2013379. https:\/\/doi.org\/10.1080\/00498254.2019.1631505","journal-title":"Xenobiotica"},{"issue":"2","key":"3692_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3346\/jkms.2015.30.2.162","volume":"30","author":"JL Yoon","year":"2015","unstructured":"Yoon JL, Cho JJ, Park KM, Noh HM, Park YS (2015) Diagnostic performance of body mass index using the Western Pacific Regional Office of World Health Organization reference standards for body fat percentage. J Korean Med Sci 30(2):162\u2013166. https:\/\/doi.org\/10.3346\/jkms.2015.30.2.162","journal-title":"J Korean Med Sci"},{"issue":"1","key":"3692_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/bcp.13431","volume":"84","author":"JJ Mao","year":"2018","unstructured":"Mao JJ, Jiao Z, Yun HY, Zhao CY, Chen HC, Qiu XY, Zhong MK (2018) External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients. Br J Clin Pharmacol 84(1):153\u2013171. https:\/\/doi.org\/10.1111\/bcp.13431","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3692_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/01.ftd.0000170029.36573.a0","volume":"27","author":"H Zahir","year":"2005","unstructured":"Zahir H, McLachlan AJ, Nelson A, McCaughan G, Gleeson M, Akhlaghi F (2005) Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients. Ther Drug Monit 27(4):422\u2013430. https:\/\/doi.org\/10.1097\/01.ftd.0000170029.36573.a0","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3692_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/00007691-200412000-00003","volume":"26","author":"C Dansirikul","year":"2004","unstructured":"Dansirikul C, Staatz CE, Duffull SB, Taylor PJ, Lynch SV, Tett SE (2004) Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Ther Drug Monit 26(6):593\u2013599. https:\/\/doi.org\/10.1097\/00007691-200412000-00003","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3692_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1055\/s-0039-1688443","volume":"39","author":"T Kourkoumpetis","year":"2019","unstructured":"Kourkoumpetis T, Levitsky J (2019) Immunosuppressive drug levels in liver transplant recipients: Impact in decision making. Semin Liver Dis 39(4):414\u2013421. https:\/\/doi.org\/10.1055\/s-0039-1688443","journal-title":"Semin Liver Dis"},{"issue":"1","key":"3692_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","volume":"82","author":"MO Karlsson","year":"2007","unstructured":"Karlsson MO, Savic RM (2007) Diagnosing model diagnostics. Clin Pharmacol Ther 82(1):17\u201320. https:\/\/doi.org\/10.1038\/sj.clpt.6100241","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3692_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/cpt.334","volume":"99","author":"DR Mould","year":"2016","unstructured":"Mould DR, D\u2019Haens G, Upton RN (2016) Clinical decision support tools: the evolution of a revolution. Clin Pharmacol Ther 99(4):405\u2013418. https:\/\/doi.org\/10.1002\/cpt.334","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"3692_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11095-020-02908-7","volume":"37","author":"T Guo","year":"2020","unstructured":"Guo T, van Hest RM, Zwep LB, Roggeveen LF, Fleuren LM, Bosman RJ, van der Voort PHJ, Girbes ARJ, Mathot RAA, Elbers PWG, van Hasselt JGC (2020) Optimizing predictive performance of Bayesian forecasting for vancomycin concentration in intensive care patients. Pharm Res 37(9):171. https:\/\/doi.org\/10.1007\/s11095-020-02908-7","journal-title":"Pharm Res"},{"issue":"6","key":"3692_CR34","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/bcp.13901","volume":"85","author":"JA Abrantes","year":"2019","unstructured":"Abrantes JA, J\u00f6nsson S, Karlsson MO, Nielsen EI (2019) Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data. Br J Clin Pharmacol 85(6):1326\u20131336. https:\/\/doi.org\/10.1111\/bcp.13901","journal-title":"Br J Clin Pharmacol"},{"key":"3692_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105448","author":"X Cai","year":"2020","unstructured":"Cai X, Song H, Jiao Z, Yang H, Zhu M, Wang C, Wei D, Shi L, Wu B, Chen J (2020) Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients. Eur J Pharm Sci. https:\/\/doi.org\/10.1016\/j.ejps.2020.105448","journal-title":"Eur J Pharm Sci"},{"key":"3692_CR36","doi-asserted-by":"publisher","first-page":"1031969","DOI":"10.3389\/fphar.2022.1031969","volume":"13","author":"XJ Cai","year":"2022","unstructured":"Cai XJ, Li RD, Li JH, Tao YF, Zhang QB, Shen CH, Zhang XF, Wang ZX, Jiao Z (2022) Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: a comparison of Michaelis-Menten and theory-based pharmacokinetic models. Front Pharmacol 13:1031969. https:\/\/doi.org\/10.3389\/fphar.2022.1031969","journal-title":"Front Pharmacol"},{"issue":"5","key":"3692_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/bcp.12830","volume":"81","author":"CY Zhao","year":"2016","unstructured":"Zhao CY, Jiao Z, Mao JJ, Qiu XY (2016) External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients. Br J Clin Pharmacol 81(5):891\u2013907. https:\/\/doi.org\/10.1111\/bcp.12830","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"3692_CR38","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/clinchem\/48.10.1668","volume":"48","author":"RH van Schaik","year":"2002","unstructured":"van Schaik RH, van der Heiden IP, van den Anker JN, Lindemans J (2002) CYP3A5 variant allele frequencies in Dutch Caucasians. Clin Chem 48(10):1668\u20131671","journal-title":"Clin Chem"},{"issue":"2","key":"3692_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00228-003-0594-2","volume":"59","author":"C Balram","year":"2003","unstructured":"Balram C, Zhou Q, Cheung YB, Lee EJ (2003) CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations. Eur J Clin Pharmacol 59(2):123\u2013126. https:\/\/doi.org\/10.1007\/s00228-003-0594-2","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3692_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00008571-200206000-00009","volume":"12","author":"S Fukuen","year":"2002","unstructured":"Fukuen S, Fukuda T, Maune H, Ikenaga Y, Yamamoto I, Inaba T, Azuma J (2002) Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population. Pharmacogenetics 12(4):331\u2013334. https:\/\/doi.org\/10.1097\/00008571-200206000-00009","journal-title":"Pharmacogenetics"},{"issue":"11","key":"3692_CR41","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.clinthera.2013.08.019","volume":"35","author":"S Vannaprasaht","year":"2013","unstructured":"Vannaprasaht S, Reungjui S, Supanya D, Sirivongs D, Pongskul C, Avihingsanon Y, Tassaneeyakul W (2013) Personalized tacrolimus doses determined by CYP3A5 Genotype for induction and maintenance phases of kidney transplantation. Clin Ther 35(11):1762\u20131769. https:\/\/doi.org\/10.1016\/j.clinthera.2013.08.019","journal-title":"Clin Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03692-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03692-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03692-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T03:06:33Z","timestamp":1720148793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03692-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3692"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03692-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3847645\/v1","asserted-by":"object"}]},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted according to an ethical standard and approved by the Institutional Review Board of the Faculty of Medicine of Chulalongkorn University, Bangkok (IRB No. 0382\/65). This study did not involve direct patient contact as it was conducted retrospectively. All data were collected exclusively from medical records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}